Issue 11, 2017

Egg-derived bioactive peptides with ACE-inhibitory properties: a literature update

Abstract

Egg proteins contain a wide set of peptide sequences which have an impact on cardiovascular health. Their modes-of-action involve, among others, the inhibition of angiotensin-converting enzyme (ACE) and antioxidant and anti-inflammatory properties. In this review, we focus particularly on ACE-inhibition and discuss recent findings in: (i) production methods for egg protein-derived ACE-inhibitory peptides, (ii) in vitro functionality of these peptides, (iii) their intestinal digestion and absorption in order to reach the target tissue, (iv) the impact of ACE-inhibitory egg-derived peptides in vivo and (v) future perspectives for the implementation of egg-derived ACE-inhibitory peptides as functional foods.

Graphical abstract: Egg-derived bioactive peptides with ACE-inhibitory properties: a literature update

Article information

Article type
Review Article
Submitted
09 Jun 2017
Accepted
30 Aug 2017
First published
25 Sep 2017

Food Funct., 2017,8, 3847-3855

Egg-derived bioactive peptides with ACE-inhibitory properties: a literature update

C. Grootaert, B. Matthijs, S. Voorspoels, S. Possemiers, G. Smagghe and J. Van Camp, Food Funct., 2017, 8, 3847 DOI: 10.1039/C7FO00839B

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements